Последние публикации
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial.
Lancet. 2007 Jul 7;370(9581):39-48. PubMed PMID: 17617271.
Lazzarin A., Campbell T., Clotet B., Johnson M., Katlama C., Moll A., Towner W., Trottier B., Peeters M., Vingerhoets J., de Smedt G, Baeten B, Beets G, Sinha R, Woodfall B; DUET-2 study group.
Читать далее
Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study).
AIDS. 2006 Apr 4;20(6):795-803. PubMed PMID: 16549962.
Castagna A, Danise A, Menzo S, Galli L, Gianotti N, Carini E, Boeri E, Galli A, Cernuschi M, Hasson H, Clementi M, Lazzarin A.
Читать далее
Mutations and Salvage (MuSa) Study Group. Comparison of a rule-based algorithm with a phenotype-based algorithm for the interpretation of HIV genotypes in guiding salvage regimens in HIV-infected patients by a randomized clinical trial: the mutations and salvage study.
Clin Infect Dis. 2006 May 15;42(10):1470-80. Epub 2006 Apr 13. PubMed PMID: 16619162.
Gianotti N., Mondino V., Rossi MC., Chiesa E., Mezzaroma I., Ladisa N., Guaraldi G., Torti C., Tarquini P., Castelli P., Di Carlo A., Boeri E., Keulen W., Kenna PM, Lazzarin A.;
Читать далее
TORO 2 Study Group. Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.
N Engl J Med. 2003. May 29;348(22):2186-95. PubMed PMID: 12773645.
Lazzarin A., Clotet B., Cooper D., Reynes J., Arastéh K., Nelson M., Katlama C., Stellbrink HJ, Delfraissy JF, Lange J., Huson L., DeMasi R., Wat C, Delehanty J., Drobnes C., Salgo M.;
Читать далее
Efficacy of low-dose intermittent subcutaneous interleukin (IL)—2 in antiviral drug--experienced human immunodeficiency virus--infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapy.
J Infect Dis. 2001 May 15;183(10):1476-84. Epub 2001 Apr 13. PubMed PMID: 11319683.
Tambussi G., Ghezzi S., Nozza S., Vallanti G., Magenta L., Guffanti M., Brambilla A., Vicenzi E., Carrera P., Racca S., Soldini L., Gianotti N., Murone M., Veglia F., Poli G., Lazzarin A.
Читать далее
Recombinant interleukin-2 for treatment of HIV reduces hepatitis C viral load in coinfected patients.
AIDS. 1999 Jan 14;13(1):140-1. PubMed PMID: 10207560.
Uberti-Foppa C, De Bona A, Morsica G, Guffanti M, Gianotti N, Boeri E, Lazzarin A.
Читать далее
Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction.
AIDS. 1997 Jan;11(1):1-17. Review. PubMed PMID: 9110070.
Cinque P., Scarpellini P., Vago L., Linde A., Lazzarin A.
Читать далее
Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.
AIDS. 1996 Nov;10(13):F45-50. PubMed PMID: 8931778.
Rizzardi GP, Barcellini W., Tambussi G., Lillo F., Malnati M., Perrin L., Lazzarin A.
Читать далее
Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study.
Am J Epidemiol. 1992 Feb 1;135(3):225-33. PubMed PMID: 1312300.
Nicolosi A., Leite ML, Musicco M., Molinari S., Lazzarin A.
Читать далее